AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Met-G1 Tablet SR

Prescription Icon
Prescription Required

Marketer

Bi-Cure Remedies

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Met-G1 Tablet SR

Glimepiride-Metformin extended-release tablets are classified as antidiabetic agents. This dual-medication formulation manages type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your glycemic response. Continuous use is crucial, even with well-controlled blood sugar, as abrupt cessation can lead to hyperglycemia and potentially serious complications including nephropathy, retinopathy, neuropathy, and peripheral vascular disease. Remember, this medication is part of a comprehensive diabetes management plan that includes diet, exercise, and weight management as recommended by your doctor. Lifestyle modifications are vital to diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to recognize its symptoms (sweating, dizziness, headache, tremor) and how to treat it. Maintain regular meals and carry a rapid-acting glucose source. Alcohol consumption should be limited due to its hypoglycemic effect. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of cardiac disease to your physician before commencing treatment, as it may be unsuitable. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring and periodic blood tests (complete blood count and liver function tests) are recommended.

Uses of Met-G1 Tablet SR

Managing type 2 diabetes

Major Benefits of Met-G1 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Met-G1 Tablet SR. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with a meal.

Common Side effects of Met-G1 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Met-G1 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Met-G1 Tablet SR. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.

How Met-G1 Tablet SR works:

Metformin and Glimepiride, combined in Met-G1 SR tablets, offer a dual approach to diabetes management. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thereby reducing blood sugar levels. Metformin, a biguanide, acts through a threefold mechanism: decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Avoid alcohol while taking Met-G1 Tablet SR.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Met-G1 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Met-G1 tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Met-G1 Tablet SR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Met-G1 Tablet SR use. Physician consultation is advised. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Met-G1 Tablet SR cautiously, potentially requiring dosage modification. Consult your physician. For those with mild to moderate liver disease, Met-G1 Tablet SR initiation is typically at a low dose; however, it's contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Met-G1 Tablet SR :

Should you forget a dose of Met-G1 Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Met-G1 Tablet SR

LabelValue
Potential for Dependence None.
Type of Treatment Medication for diabetes

FAQs on Met-G1 Tablet SR

Store this medication in its original, tightly sealed container or packaging, following the storage instructions provided on the label. Discard any leftover medication. Prevent access by children, pets, and others.
Indeed, Met-G1 Tablet SR can result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed MALA (Metformin-associated lactic acidosis), this uncommon adverse reaction to metformin poses a significant risk to individuals with pre-existing kidney impairment, the elderly, or those who consume substantial alcohol. Symptoms may manifest as muscle aches or weakness, lightheadedness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal discomfort, or a slow pulse. Should these symptoms appear, discontinue Met-G1 Tablet SR use and seek immediate medical attention.
Glimepiride and Metformin, combined as Met-G1 SR Tablet, treat type 2 diabetes mellitus in adults. This medication enhances blood sugar control when used alongside a balanced diet and regular physical activity. Glimepiride functions by stimulating insulin secretion from the pancreas, thus reducing blood glucose. Metformin reduces liver glucose production and increases insulin responsiveness. This dual-drug formulation is unsuitable for managing type 1 diabetes mellitus.
Met-G1 Tablet SR may cause common side effects including low blood sugar (hypoglycemia), taste disturbances, nausea, abdominal pain, diarrhea, and headache. Rare but potentially serious adverse reactions such as lactic acidosis may occur. Prolonged use can result in vitamin B12 deficiency.
Prolonged Met-G1 Tablet SR administration can induce Vitamin B12 deficiency by hindering its gastric absorption. This deficiency, if left unaddressed, may lead to anemia, neurological complications including paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive impairment, and ataxia. Preventive measures suggested by some studies include supplemental Vitamin B12 at least annually.
Indeed, Met-G1 Tablet SR can induce hypoglycemia, characterized by low blood glucose. Manifestations of this condition encompass nausea, headache, irritability, hunger pangs, sweating, vertigo, tachycardia, and feelings of anxiety or tremor. The likelihood increases with missed or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying readily available glucose sources, such as glucose tablets, honey, or fruit juice, is advisable.
Combining Met-G1 Tablet SR and alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia) and a heightened likelihood of lactic acidosis.
Met-G1 Tablet SR
48
MRP 58
17% off